m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00064)
| Target Name | hsa_circ_0000231 (circ_ARHGAP12) | ||||
|---|---|---|---|---|---|
| Gene Name | Circ_ARHGAP12 | ||||
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
Circ_ARHGAP12
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) [READER]
| In total 1 item(s) under this regulator | ||||
| Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
| Response Summary | m6A-modified hsa_circ_0000231 (circARHGAP12) interacts with IGF2BP2 to enhance FOXM1 mRNA stability, forming circARHGAP12/IGF2BP2/FOXM1 complex, thereby promoting the proliferation and migration of cervical cancer cells. | |||
| Target Regulation | Up regulation | |||
| Responsed Disease | Cervical cancer | ICD-11: 2C77 | ||
| Pathway Response | Cellular senescence | hsa04218 | ||
| In-vitro Model | C-33 A | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1094 |
| Ca Ski | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1100 | |
| HaCaT | Normal | Homo sapiens | CVCL_0038 | |
| HT-3 | Cervical carcinoma | Homo sapiens | CVCL_1293 | |
| SiHa | Cervical squamous cell carcinoma | Homo sapiens | CVCL_0032 | |
| In-vivo Model | CircARHGAP12-stable knockdown cervical cancer cells (100 uL PBS containing 5 × 106 cells) were subcutaneously injected into the lateral flank of BALB/c nude mice. | |||
Cervical cancer [ICD-11: 2C77]
| In total 1 item(s) under this disease | ||||
| Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
| Response Summary | m6A-modified hsa_circ_0000231 (circARHGAP12) interacts with IGF2BP2 to enhance FOXM1 mRNA stability, forming circARHGAP12/IGF2BP2/FOXM1 complex, thereby promoting the proliferation and migration of cervical cancer cells. | |||
| Responsed Disease | Cervical cancer [ICD-11: 2C77] | |||
| Target Regulator | Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) | READER | ||
| Target Regulation | Up regulation | |||
| Pathway Response | Cellular senescence | hsa04218 | ||
| In-vitro Model | C-33 A | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1094 |
| Ca Ski | Cervical squamous cell carcinoma | Homo sapiens | CVCL_1100 | |
| HaCaT | Normal | Homo sapiens | CVCL_0038 | |
| HT-3 | Cervical carcinoma | Homo sapiens | CVCL_1293 | |
| SiHa | Cervical squamous cell carcinoma | Homo sapiens | CVCL_0032 | |
| In-vivo Model | CircARHGAP12-stable knockdown cervical cancer cells (100 uL PBS containing 5 × 106 cells) were subcutaneously injected into the lateral flank of BALB/c nude mice. | |||
Full List of Crosstalk(s) between m6A Modification and Epigenetic Regulation Related to This Regulator
Non-coding RNA
m6A Regulator: Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2)
| In total 1 item(s) under this m6A regulator | ||
| Crosstalk ID: M6ACROT05505 | ||
| Epigenetic Regulator | hsa_circ_0000231 (Circ_ARHGAP12) | |
| Regulated Target | Forkhead box protein M1 (FOXM1) | |
| Crosstalk relationship | m6A → ncRNA | |
| Disease | Cervical cancer | |